A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect-Reference-Cited by-同舟云学术

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect

Published:2004-09 Issue:3 Volume:148 Page:422-429
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Webb John G.,Pate Gordon E.,Humphries Karin H.,Buller Christopher E.,Shalansky Stephen,Al Shamari Ali,Sutander Anton,Williams Tracey,Fox Rebecca S.,Levin Adeera

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Oxidant mechanisms in toxic acute renal failure;Baliga;Am J Kidney Dis,1997

2. Oxygen free radicals and contrast nephropathy;Katholi;Am J Kidney Dis,1998

3. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency;Gruberg;J Am Coll Cardiol,2000

4. Prevention of radiocontrast-induced nephropathy;Baker;Catheter Cardiovasc Interv,2003

5. N-acetylcysteine improves coronary and peripheral vascular function;Andrews;J Am Coll Cardiol,2001

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-acetylcysteine in Kidney Disease: Molecular Mechanisms, Pharmacokinetics, and Clinical Effectiveness;Kidney International Reports;2024-07

2. Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice;Nature Communications;2023-03-04

3. Iodinated Contrast and Acute Kidney Injury;Evidence‐Based Nephrology;2022-11-18

4. Meta-analytic Techniques to Assess the Association Between N-acetylcysteine and Acute Kidney Injury After Contrast Administration;JAMA Network Open;2022-07-05

5. Remote ischemic preconditioning for prevention of contrast-induced acute kidney injury in patients of CKD stage III and IV undergoing elective coronary angiography: A randomized controlled trial;Indian Journal of Nephrology;2021